Keyword: Novartis


Novartis Confirms 8,000 Global Jobs Will be Axed

29.06.2022 -

Novartis has confirmed reports by Swiss daily newspaper Tages-Anzeiger that it plans to slash 8,000 jobs worldwide.


Novartis Pledges to Fight Tropical Diseases and Malaria

28.06.2022 -

Swiss drugmaker Novartis has made a five-year financial commitment of $250 million to fight neglected tropical diseases (NTDs) and malaria.


Samsung Biologics in $81 Million Deal with Novartis

13.06.2022 -

In the their first-ever collaboration, South Korea’s Samsung Biologics and Switzerland’s Novartis have inked an initial $81 million contract manufacturing and development...


Sandoz Launches Generic Combigan Drops

19.04.2022 -

Novartis subsidiary Sandoz has launched a generic version of Combigan, the ocular hypertensiondrug made by AbbVie’s Allergan arm. The copy of the off-patent eye drops...

Markets & Companies

After the Big Covid-19 Storm

19.04.2022 -

What does 2022 hold for the biopharma industry? Which companies can play at the forefront in terms of products as well as business? Covid-19 will continue to be a...


Novartis Creates new Innovative Medicines Unit

05.04.2022 -

Swiss pharma powerhouse Novartis is merging its pharmaceuticals and oncology businesses into a new unit called Innovative Medicines (IM). The restructuring that will...


Novartis Takes Gyroscope Therapeutics for $1.5 Billion

22.02.2022 -

Swiss pharma Novartis has acquired Gyroscope Therapeutics, a clinical-stage gene therapy company focused on diseases of the eye, from Syncona, a UK-based firm that says...


Private Equity Buyers Seen as Circling Sandoz

02.02.2022 -

US private equity firms Blackstone and Carlyle may make a joint offer for the Novartis generics unit Sandoz, Bloomberg reports. With six other possible bidders seen as...